公开(公告)号：US20240360115A1

公开(公告)日：2024-10-31

申请号：US18764292

申请日：2024-07-04

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: C07D413/06 ,  A61K31/341 ,  A61K31/501 ,  A61K45/06 ,  A61P35/02 ,  C07D207/36 ,  C07D207/38 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/30 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D417/06 ,  C07D471/04 ,  C12N7/00

CPC classification number: C07D413/06 ,  A61K31/501 ,  A61K45/06 ,  A61P35/02 ,  C07D207/36 ,  C07D207/38 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/30 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D417/06 ,  C07D471/04 ,  C12N7/00 ,  A61K31/341 ,  A61K2300/00 ,  C12N2710/10334 ,  C12N2710/10351 ,  C12N2710/10352 ,  C12N2710/16651 ,  C12N2710/24151 ,  C12N2750/14151 ,  C12N2760/16134 ,  C12N2760/16151 ,  C12N2760/16152 ,  C12N2760/20234 ,  C12N2760/20251 ,  C12N2760/20252

Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US20220220101A1

公开(公告)日：2022-07-14

申请号：US17710386

申请日：2022-03-31

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: C07D413/06 ,  C07D237/14 ,  C07D207/38 ,  C07D307/60 ,  C07D307/66 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/12 ,  C07D409/06 ,  C07D307/30 ,  C07D307/58 ,  C07D405/06 ,  A61K45/06 ,  A61K31/501 ,  C12N7/00 ,  C07D207/36 ,  C07D207/456 ,  C07D317/64 ,  C07D417/06 ,  C07D471/04 ,  A61P35/02 ,  C07D209/48 ,  C07D231/08

Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US11339146B2

公开(公告)日：2022-05-24

申请号：US16877291

申请日：2020-05-18

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: A61K31/501 ,  C07D413/06 ,  C07D237/14 ,  C07D207/38 ,  C07D307/60 ,  C07D307/66 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/12 ,  C07D409/06 ,  C07D307/30 ,  C07D307/58 ,  C07D405/06 ,  A61K45/06 ,  C12N7/00 ,  C07D207/36 ,  C07D207/456 ,  C07D317/64 ,  C07D417/06 ,  C07D471/04 ,  A61P35/02 ,  C07D209/48 ,  C07D231/08 ,  A61K31/341

Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US20180305345A1

公开(公告)日：2018-10-25

申请号：US15542480

申请日：2016-01-26

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Fabrice Le Boeuf ,  John C. Bell ,  Andrew Macklin ,  Jeffrey Smith

IPC: C07D413/06 ,  C07D207/38 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/12 ,  C07D409/06 ,  C07D471/04 ,  A61P35/02

CPC classification number: C07D413/06 ,  A61K31/341 ,  A61K31/4015 ,  A61K31/402 ,  A61K2300/00 ,  A61P35/02 ,  C07D207/36 ,  C07D207/38 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/30 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D417/06 ,  C07D471/04 ,  C12N7/00 ,  C12N2710/10334 ,  C12N2710/10351 ,  C12N2710/10352 ,  C12N2710/16651 ,  C12N2710/24151 ,  C12N2750/14151 ,  C12N2760/16134 ,  C12N2760/16151 ,  C12N2760/16152 ,  C12N2760/20234 ,  C12N2760/20251 ,  C12N2760/20252

Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US12195451B2

公开(公告)日：2025-01-14

申请号：US17710386

申请日：2022-03-31

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: C07D207/38 ,  A61K31/501 ,  A61K45/06 ,  A61P35/02 ,  C07D207/36 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/30 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D413/06 ,  C07D417/06 ,  C07D471/04 ,  C12N7/00 ,  A61K31/341

Abstract: Provided are compounds of Formula III that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US10654839B2

公开(公告)日：2020-05-19

申请号：US15546167

申请日：2016-01-26

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: C07D207/36 ,  C07D413/06 ,  C07D237/14 ,  C07D207/38 ,  C07D307/60 ,  C07D307/66 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/12 ,  C07D409/06 ,  C07D307/30 ,  C07D307/58 ,  C07D405/06 ,  A61K45/06 ,  C12N7/00 ,  C07D207/456 ,  C07D317/64 ,  C07D417/06 ,  C07D471/04 ,  A61P35/02 ,  C07D209/48 ,  C07D231/08 ,  A61K31/341

Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided. Compounds of Formula (II):

公开(公告)号：US20180112190A1

公开(公告)日：2018-04-26

申请号：US15546167

申请日：2016-01-26

Applicant: Ottawa Hospital Research Institute ,  University of Ottawa

Inventor： Jean-Simon Diallo ,  Christopher Noyce Boddy ,  Mark Dornan ,  Ramya Krishnan ,  Rozanne Arulanandam ,  Fabrice Le Boeuf ,  Jeffrey Smith ,  Andrew Macklin

IPC: C12N7/00 ,  C07D207/36 ,  C07D307/60 ,  C07D307/66 ,  C07D307/58 ,  C07D317/64 ,  C07D237/14 ,  C07D207/456 ,  C07D405/04 ,  C07D471/04 ,  C07D403/06 ,  C07D405/12 ,  C07D401/06 ,  C07D307/30 ,  C07D417/06 ,  C07D413/06

CPC classification number: C07D413/06 ,  A61K31/341 ,  A61K45/06 ,  A61K2300/00 ,  A61P35/02 ,  C07D207/36 ,  C07D207/38 ,  C07D207/456 ,  C07D209/48 ,  C07D231/08 ,  C07D237/14 ,  C07D307/30 ,  C07D307/58 ,  C07D307/60 ,  C07D307/66 ,  C07D317/64 ,  C07D401/06 ,  C07D403/06 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D417/06 ,  C07D471/04 ,  C12N7/00 ,  C12N2710/10334 ,  C12N2710/10351 ,  C12N2710/10352 ,  C12N2710/16651 ,  C12N2710/24151 ,  C12N2750/14151 ,  C12N2760/16134 ,  C12N2760/16151 ,  C12N2760/16152 ,  C12N2760/20234 ,  C12N2760/20251 ,  C12N2760/20252

Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.

公开(公告)号：US11802292B2

公开(公告)日：2023-10-31

申请号：US16959632

申请日：2019-01-04

Applicant: OTTAWA HOSPITAL RESEARCH INSTITUTE ,  TURNSTONE BIOLOGICS CORP.

Inventor： John C. Bell ,  Fabrice Le Boeuf ,  Michael S. Huh ,  Matthew Y. Tang ,  Adrian Pelin ,  Brian Andrew Keller ,  Caroline J. Breitbach ,  Michael F. Burgess ,  Steven H. Bernstein

IPC: C12N15/86 ,  A61K35/768 ,  C07K14/545 ,  C12N7/00 ,  C12N9/22

CPC classification number: C12N15/86 ,  A61K35/768 ,  C07K14/545 ,  C12N7/00 ,  C12N9/22 ,  C12N2710/24121 ,  C12N2710/24132 ,  C12Y306/01023

Abstract: The disclosure relates to modified orthopoxvirus vectors, as well as methods of using the same for the treatment of various cancers. The disclosure provides modified orthopoxvirus vectors that exhibit various beneficial therapeutic activities, including enhanced oncolytic activity, spread of infection, immune evasion, tumor persistence, capacity for incorporation of exogenous DNA sequences and safety. The viruses we have discovered are also amenable to large scale manufacturing protocols.

公开(公告)号：US20150202240A1

公开(公告)日：2015-07-23

申请号：US14569416

申请日：2014-12-12

Applicant: Ottawa Hospital Research Institute

Inventor： John Bell ,  Jean-Simon Diallo ,  Fabrice Le Boeuf

IPC: A61K35/766 ,  A61K31/275 ,  C12N7/00 ,  A61K31/365

CPC classification number: A61K35/766 ,  A61K31/275 ,  A61K31/341 ,  A61K31/365 ,  A61K38/00 ,  A61K45/06 ,  C07C49/675 ,  C07C49/747 ,  C07C205/37 ,  C07C217/84 ,  C07C233/32 ,  C07C233/38 ,  C07C243/38 ,  C07C255/37 ,  C07C311/44 ,  C07C323/42 ,  C07C323/60 ,  C07C335/16 ,  C07C337/06 ,  C07C337/08 ,  C07C2601/02 ,  C07C2601/14 ,  C07C2603/26 ,  C07C2603/34 ,  C07D213/75 ,  C07D233/90 ,  C07D257/04 ,  C07D307/58 ,  C07D319/20 ,  C07D333/04 ,  C07D403/12 ,  C07D409/12 ,  C12N7/00 ,  C12N2760/20232 ,  C12N2760/20251 ,  A61K2300/00

Abstract: Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.

Abstract translation: 提供的病毒敏化化合物通过增加病毒在细胞中的扩散，增加病毒在细胞中的滴度或增加病毒对细胞的细胞毒性而增强病毒的功效。 还提供了其他用途，组合物和使用方法。

公开(公告)号：US20230022757A1

公开(公告)日：2023-01-26

申请号：US17694115

申请日：2022-03-14

Applicant: OTTAWA HOSPITAL RESEARCH INSTITUTE

Inventor： John C. Bell ,  Fabrice Le Boeuf ,  Michael S. Huh ,  Matthew Y. Tang ,  Brian Andrew Keller ,  Adrian Pelin

IPC: C12N15/86 ,  A61P31/20 ,  A61P35/00 ,  A61K39/285

Abstract: The disclosure relates to modified vaccinia virus vectors derived from the Copenhagen strain of vaccinia virus, as well as methods of using the same for the treatment of various cancers. The disclosure provides modified Copenhagen-derived vaccinia virus vectors that exhibit various beneficial therapeutic activities, including enhanced oncolytic activity, spread of infection, immune evasion, tumor persistence, capacity for incorporation of exogenous DNA sequences, amenability for large scale manufacturing, and safety.